Annelien J.M. Zweemer

Functionally biased modulation of A3 adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers

Zhan‐Guo Gao, Dennis Verzijl, Annelien J.M. Zweemer et al. · Biochemical Pharmacology · 2011 · 72 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Multiple Binding Sites for Small-Molecule Antagonists at the CC Chemokine Receptor 2

Annelien J.M. Zweemer, Indira Nederpelt, Hilde Vrieling et al. · Molecular Pharmacology · 2013 · 68 citations

Medicine, Medicinal Chemistry, Pharmacology +17

False Positives in a Reporter Gene Assay: Identification and Synthesis of Substituted <i>N</i>-Pyridin-2-ylbenzamides as Competitive Inhibitors of Firefly Luciferase

Laura H. Heitman, Jacobus P. D. van Veldhoven, Annelien J.M. Zweemer et al. · Journal of Medicinal Chemistry · 2008 · 66 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

A Series of 2,4-Disubstituted Quinolines as a New Class of Allosteric Enhancers of the Adenosine A₃Receptor

Laura H. Heitman, Anikó Göblyös, Annelien J.M. Zweemer et al. · Journal of Medicinal Chemistry · 2009 · 63 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Structure–Kinetic Relationships—An Overlooked Parameter in Hit-to-Lead Optimization: A Case of Cyclopentylamines as Chemokine Receptor 2 Antagonists

M. Viļums, Annelien J.M. Zweemer, Zhiyi Yu et al. · Journal of Medicinal Chemistry · 2013 · 63 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17